RELENZA (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the RELENZA drug offered from Physicians Total Care, Inc.. This Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: zanamivir
SUBSTANCE NAME: ZANAMIVIR
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: POWDER
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-01-20
END MARKETING DATE: 0000-00-00


RELENZA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRELENZA from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2009-01-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-4377_94fe9007-c54b-4911-9363-9ca1c3e840dc
PRODUCT NDC: 54868-4377
APPLICATION NUMBER: NDA021036

Other ZANAMIVIR Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions Inc.RELENZA
GlaxoSmithKline LLCRELENZA
Physicians Total Care, Inc.RELENZA